Zobrazeno 1 - 10
of 16 692
pro vyhledávání: ''
Autor:
Hee Seung Kim, Jae Weon Kim, Hyun Hoon Chung, Ga Won Yim, Noh Hyun Park, Aeran Seol, Yong Sang Song, Se Ik Kim, Joo Yeon Chung, Maria Lee
Publikováno v:
Cancer Research and Treatment. 54:1219-1229
Purpose This study aimed to identify patients who would benefit from third and subsequent lines of chemotherapy in recurrent epithelial ovarian cancer (EOC).Materials and Methods Recurrent EOC patients who received third, fourth, or fifth-line pallia
Autor:
Bo La Yun, Eunyoung Kang, Hee-Chul Shin, Sun Mi Kim, Eun Kyu Kim, Se Hyun Kim, Mijung Jang, Jee Hyun Kim, So Yeon Park, Yeshong Park, Kyung-Hwak Yoon, Koung Jin Suh
Publikováno v:
Cancer Research and Treatment. 54:1081-1090
PurposeEstrogen receptor (ER) expression in breast cancer plays an essential role in carcinogenesis and disease progression. Recently, tumors with low level (1-10%) of ER expression have been separately defined as ER Low Positive (ERlow). It is sugge
Publikováno v:
Cancer Research and Treatment. 54:996-1004
Purpose The illness-death model (IDM) is a comprehensive approach to evaluate the relationship between relapse and death. This study aimed to illustrate the value of the IDM for identifying risk factors and evaluating predictive probabilities for rel
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:553-559
Background: The aim of the study is to evaluate clinical outcomes of patients with ovarian metastases from colorectal cancer (OM-CRC) treated with complete resection combined with chemotherapy and ...
Autor:
Byeong-Ho Jeong, Kyungjong Lee, O Jung Kwon, Noeul Kang, Kihwan Kim, Ho Yun Lee, Sang-Won Um, Myung-Ju Ahn, Jeonghee Cho, Hojoong Kim
Publikováno v:
Cancer Research and Treatment. 54:817-826
Purpose The role of epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs) in the management of persistent subsolid nodules (SSNs) is unclear. This study aimed to investigate the impact of EGFR-TKIs on concurrent SSNs in patients w
Autor:
Eun Jung Park, Kang Young Lee, Jae-Hoon Lee, Hye Sun Lee, Su Jin Shin, Dong-Hee Lee, Sang Won Lee, Jeonghyun Kang, Seung Hyuk Baik
Publikováno v:
Cancer Research and Treatment. 54:860-872
PurposeThe clinical significance of body mass index (BMI) on long-term outcomes has not been extensively investigated in Asian patients with colorectal cancer (CRC). This study aims to describe the association between BMI and survival, plus providing
Autor:
Hiroji Iwata, Masaya Hattori, Nanae Horisawa, Yuka Endo, Daiki Takatsuka, Yuri Ozaki, Akiyo Yoshimura, Masataka Sawaki, Ayumi Kataoka, Kazuki Nozawa, Haruru Kotani
Publikováno v:
Anticancer Research. 42:3735-3742
Background: Although few patients with breast cancer experience tumor progression during neoadjuvant systemic therapy (NST), their extremely poor outcomes are similar to patients who fail to achieve pathological complete response (pCR). No reports ha
Publikováno v:
Cancer Research and Treatment. 54:469-477
Purpose In hormone receptor-positive, human epidermal growth factor receptor 2–negative metastatic breast cancer (HR+ HER2–MBC), the mainstay treatment options include cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and everolimus (EVE) in combi
Autor:
Seock-Ah Im, Se Hyun Kim, So Yeon Park, Tae Yong Kim, Koung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, In Ae Park, Jung Sun Kim, Jee Hyun Kim, Sae-Won Han, Go-Un Woo, Miso Kim, Dae-Won Lee
Publikováno v:
Cancer Research and Treatment. 54:488-496
PurposeWe aimed to assess the real-world efficacy of nab-paclitaxel in metastatic breast cancer patients.Materials and MethodsThis is a retrospective study performed in two tertiary referral hospitals in Korea. Patients with metastatic breast cancer
Autor:
Jaehyeon Park, Kyubo Kim, Yeon Joo Kim, Jihye Cha, Juree Kim, In Young Jo, Jeanny Kwon, Ik Jae Lee, Kyung Hwan Shin, Yong Bae Kim, Jung Hoon Kim, Su Ssan Kim, Yeon-Joo Kim, Jinhee Kim, Myungsoo Kim
Publikováno v:
Cancer Research and Treatment. 54:478-487
Purpose This study aimed to investigate the impact of postoperative radiotherapy (PORT) in de novo metastatic breast cancer (dnMBC) patients undergoing planned primary tumor resection (PTR) and to identify the subgroup of patients who would most bene